News
According to a new study in Haemophilia, up to 60% of patients with severe HA have no known family history, making early ...
These tools, available through the myCigna member portal, are designed to make navigating health insurance more ...
Ibtrozi had a 90% response rate in treatment naïve adults with locally advanced or metastatic ROS1-positive non-small cell ...
The company's CEO points to using a subscription-based model, being a platform that allows for technology integration and scale and transparency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results